B
buffness
Guest
Anabolic Steroid Control Act of 2004
--------------------------------------------------------------------------------
Anabolic Steroid Control Act of 2004
(Bye Bye 1-AD, Methyl-1-Test, and others)
October 22, 2004 - 5pm
S. 2195, the Anabolic Steroid Control Act of 2004, was signed by President Bush on Friday, October 22. It is amazing that only 14 years earlier, in 1990, anabolic steroids were banned. In 90 days, around January 22, 2005, selling andro, methyl-1-test, and other popular pro-hormones will be in the same legal status as other drugs, like cocaine and heroin. (Yes, we are living in the United States). It looks like besides the 18 new substances listed, in expands the act to include all prohormones and prosteroid supplements. (DHEA, estrogens and a few others were spared the act - for now). So buy all that you can now, before it goes away, like ephedra did.
This bill, which was introduced by Senators Joseph Biden (D-Del.) and Orrin Hatch (R-Utah), provided for the listing of steroid hormone precursors such as androstenedione ("andro") under the Controlled Substances Act. Such action effectively prohibits the marketing of these substances as dietary supplements by regulating them as Schedule III controlled substances. The U.S. Anti-Doping Agency (USADA) has called steroid precursors "the functional equivalent of steroids."
Congressman John Sweeney, another sponsor of the bill has said ?Today is a great victory for parents of athletes everywhere,? said Sweeney. ?No longer will these dangerous products be marketed to our nation?s youth, many of who are unaware of their harmful side effects. Starting today, we?ve made it a little easier for parents in their continuing struggle to keep their children safe from the dangers of illicit drugs.?
The legislation adds 18 substances to the list of banned anabolic steroids. Here is the list of banned items:
androstanediol--
3b,17b-dihydroxy-5a-androstane; and
3a,17b-dihydroxy-5a-androstane;
androstanedione (5a-androstan-3,17-dione);
androstenediol--
1-androstenediol (3b,17b-dihydroxy-5a-androst-1-ene);
1-androstenediol (3a,17b-dihydroxy-5a-androst-1-ene);
4-androstenediol (3b,17b-dihydroxy-androst-4-ene); and
5-androstenediol (3b,17b-dihydroxy-androst-5-ene);
androstenedione--
1-androstenedione ([5a]-androst-1-en-3,17-dione);
4-androstenedione (androst-4-en-3,17-dione); and
5-androstenedione (androst-5-en-3,17-dione);
bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
clostebol (4-chloro-17b-hydroxyandrost-4-en-3-one);
dehydrochloromethyltestosterone (4-chloro-17b-hydroxy-17a-methyl-androst-1,4-dien-3-one);
1-dihydrotestosterone (a.k.a. `1-testosterone') (17b-hydroxy-5a-androst-1-en-3-one);
4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-one);
ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
fluoxymesterone (9-fluoro-17a-methyl-11b,17b-dihydroxyandrost-4-en-3-one);
formebolone (2-formyl-17a-methyl-11a,17b-dihydroxyandrost-1,4-dien-3-one);
furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-furazan);
13a-ethyl-17a-hydroxygon-4-en-3-one;
4-hydroxytestosterone (4,17b-dihydroxy-androst-4-en-3-one);
4-hydroxy-19-nortestosterone (4,17b-dihydroxy-estr-4-en-3-one);
mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-one);
mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-one);
methandienone (17a-methyl-17b-hydroxyandrost-1,4-dien-3-one);
methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-ene);
methenolone (1-methyl-17b-hydroxy-5a-androst-1-en-3-one);
methyltestosterone (17a-methyl-17b-hydroxyandrost-4-en-3-one);
mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-one);
17a-methyl-*1-dihydrotestosterone (17b-hydroxy-17a-methyl-5a-androst-1-en-3-one) (a.k.a. `17-a-methyl-1-testosterone');
nandrolone (17b-hydroxyestr-4-en-3-one);
norandrostenediol--
19-nor-4-androstenediol (3b, 17b-dihydroxyestr-4-ene);
19-nor-4-androstenediol (3a, 17b-dihydroxyestr-4-ene);
19-nor-5-androstenediol (3b, 17b-dihydroxyestr-5-ene); and
19-nor-5-androstenediol (3a, 17b-dihydroxyestr-5-ene);
norandrostenedione--
19-nor-4-androstenedione (estr-4-en-3,17-dione); and
19-nor-5-androstenedione (estr-5-en-3,17-dione;
norbolethone (13b,17a-diethyl-17b-hydroxygon-4-en-3-one);
norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-one);
oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-androstan-3-one);
oxymesterone (17a-methyl-4,17b-dihydroxyandrost-4-en-3-one);
oxymetholone (17a-methyl-2-hydroxymethylene-17b-hydroxy-[5a]-androstan-3-one);
stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-eno[3,2-c]-pyrazole);
stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-en-3-one);
testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
testosterone (17b-hydroxyandrost-4-en-3-one);
tetrahydrogestrinone (13b,17a-diethyl-17b-hydroxygon-4,9,11-trien-3-one);
trenbolone (17b-hydroxyestr-4,9,11-trien-3-one); and
any salt, ester, or ether of a drug or substance described in this paragraph.'; and
--------------------------------------------------------------------------------
Here is the complete bill...
108th CONGRESS, 2d Session, S. 2195
To amend the Controlled Substances Act to clarify the definition of anabolic steroids and to provide for research and education activities relating to steroids and steroid precursors.
IN THE SENATE OF THE UNITED STATES
March 11, 2004
Mr. BIDEN (for himself, Mr. HATCH, Mr. GRASSLEY, Mr. HARKIN, Mr. STEVENS, Mr. MCCAIN, Mr. NELSON of Florida, Mrs. FEINSTEIN, Mr. ALLEN, and Ms. MURKOWSKI) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
A BILL: To amend the Controlled Substances Act to clarify the definition of anabolic steroids and to provide for research and education activities relating to steroids and steroid precursors.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the `Anabolic Steroid Control Act of 2004'.
SEC. 2. AMENDMENTS TO THE CONTROLLED SUBSTANCES ACT.
(a) DEFINITIONS- Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended--
(1) in paragraph (41)--
(A) by realigning the margin so as to align with paragraph (40); and
(B) by striking subparagraph (A) and inserting the following:
`(A) The term `anabolic steroid' means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone), and includes--
`(i) androstanediol--
`(I) 3b,17b-dihydroxy-5a-androstane; and
`(II) 3a,17b-dihydroxy-5a-androstane;
`(ii) androstanedione (5a-androstan-3,17-dione);
`(iii) androstenediol--
`(I) 1-androstenediol (3b,17b-dihydroxy-5a-androst-1-ene);
`(II) 1-androstenediol (3a,17b-dihydroxy-5a-androst-1-ene);
`(III) 4-androstenediol (3b,17b-dihydroxy-androst-4-ene); and
`(IV) 5-androstenediol (3b,17b-dihydroxy-androst-5-ene);
`(iv) androstenedione--
`(I) 1-androstenedione ([5a]-androst-1-en-3,17-dione);
`(II) 4-androstenedione (androst-4-en-3,17-dione); and
`(III) 5-androstenedione (androst-5-en-3,17-dione);
`(v) bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
`(vi) boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
`(vii) calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
`(viii) clostebol (4-chloro-17b-hydroxyandrost-4-en-3-one);
`(ix) dehydrochloromethyltestosterone (4-chloro-17b-hydroxy-17a-methyl-androst-1,4-dien-3-one);
`(x) *1-dihydrotestosterone (a.k.a. `1-testosterone') (17b-hydroxy-5a-androst-1-en-3-one);
`(xi) 4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
`(xii) drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-one);
`(xiii) ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
`(xiv) fluoxymesterone (9-fluoro-17a-methyl-11b,17b-dihydroxyandrost-4-en-3-one);
`(xv) formebolone (2-formyl-17a-methyl-11a,17b-dihydroxyandrost-1,4-dien-3-one);
`(xvi) furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-furazan);
`(xvii) 13a-ethyl-17a-hydroxygon-4-en-3-one;
`(xviii) 4-hydroxytestosterone (4,17b-dihydroxy-androst-4-en-3-one);
`(xix) 4-hydroxy-19-nortestosterone (4,17b-dihydroxy-estr-4-en-3-one);
`(xx) mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-one);
`(xxi) mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-one);
`(xxii) methandienone (17a-methyl-17b-hydroxyandrost-1,4-dien-3-one);
`(xxiii) methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-ene);
`(xxiv) methenolone (1-methyl-17b-hydroxy-5a-androst-1-en-3-one);
`(xxv) methyltestosterone (17a-methyl-17b-hydroxyandrost-4-en-3-one);
`(xxvi) mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-one);
`(xxvii) 17a-methyl-*1-dihydrotestosterone (17b-hydroxy-17a-methyl-5a-androst-1-en-3-one) (a.k.a. `17-a-methyl-1-testosterone');
`(xxviii) nandrolone (17b-hydroxyestr-4-en-3-one);
`(xxix) norandrostenediol--
`(I) 19-nor-4-androstenediol (3b, 17b-dihydroxyestr-4-ene);
`(II) 19-nor-4-androstenediol (3a, 17b-dihydroxyestr-4-ene);
`(III) 19-nor-5-androstenediol (3b, 17b-dihydroxyestr-5-ene); and
`(IV) 19-nor-5-androstenediol (3a, 17b-dihydroxyestr-5-ene);
`(xxx) norandrostenedione--
`(I) 19-nor-4-androstenedione (estr-4-en-3,17-dione); and
`(II) 19-nor-5-androstenedione (estr-5-en-3,17-dione;
`(xxxi) norbolethone (13b,17a-diethyl-17b-hydroxygon-4-en-3-one);
`(xxxii) norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
`(xxxiii) norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-one);
`(xxxiv) oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-androstan-3-one);
`(xxxv) oxymesterone (17a-methyl-4,17b-dihydroxyandrost-4-en-3-one);
`(xxxvi) oxymetholone (17a-methyl-2-hydroxymethylene-17b-hydroxy-[5a]-androstan-3-one);
`(xxxvii) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-eno[3,2-c]-pyrazole);
`(xxxviii) stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-en-3-one);
`(xxxix) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
`(xl) testosterone (17b-hydroxyandrost-4-en-3-one);
`(xli) tetrahydrogestrinone (13b,17a-diethyl-17b-hydroxygon-4,9,11-trien-3-one);
`(xlii) trenbolone (17b-hydroxyestr-4,9,11-trien-3-one); and
`(xliii) any salt, ester, or ether of a drug or substance described in this paragraph.'; and
(2) in paragraph (44), by inserting `anabolic steroids,' after `marihuana,'.
(b) AUTHORITY AND CRITERIA FOR CLASSIFICATION- Section 201(g) of the Controlled Substances Act (21 U.S.C. 811(g)) is amended--
(1) in paragraph (1), by striking `substance from a schedule if such substance' and inserting `drug which contains a controlled substance from the application of titles II and III of the Comprehensive Drug Abuse Prevention and Control Act (21 U.S.C. 802 et seq.) if such drug'; and
(2) in paragraph (3), by adding at the end the following:
`(C) Upon the recommendation of the Secretary of Health and Human Services, a compound, mixture, or preparation which contains any anabolic steroid, which is intended for administration to a human being or an animal, and which, because of its concentration, preparation, formulation or delivery system, does not present any significant potential for abuse.'.
(c) ANABOLIC STEROIDS CONTROL ACT- Section 1903 of the Anabolic Steroids Control Act of 1990 (Public Law 101-647) is amended--
(1) by striking subsection (a); and
(2) by redesignating subsections (b) and (c) as subsections (a) and (b), respectively.
SEC. 3. SENTENCING COMMISSION GUIDELINES.
The United States Sentencing Commission shall--
(1) review the Federal sentencing guidelines with respect to offenses involving anabolic steroids;
(2) consider amending the Federal sentencing guidelines to provide for increased penalties with respect to offenses involving anabolic steroids in a manner that reflects the seriousness of such offenses and the need to deter anabolic steroid trafficking and use; and
(3) take such other action that the Commission considers necessary to carry out this section.
SEC. 4. PREVENTION AND EDUCATION PROGRAMS.
(a) IN GENERAL- The Secretary of Health and Human Services (referred to in this Act as the `Secretary') shall award grants to public and nonprofit private entities to enable such entities to carry out science-based education programs in elementary and secondary schools to highlight the harmful effects of anabolic steroids.
(b) ELIGIBILITY-
(1) APPLICATION- To be eligible for grants under subsection (a), an entity shall prepare and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require.
(2) PREFERENCE- In awarding grants under subsection (a), the Secretary shall give preference to applicants that intend to use grant funds to carry out programs based on--
(A) the Athletes Training and Learning to Avoid Steroids program;
(B) the Athletes Targeting Healthy Exercise and Nutrition Alternatives program; and
(C) other programs determined to be effective by the National Institute on Drug Abuse.
(c) USE OF FUNDS- Amounts received under a grant under subsection (a) shall be used primarily for education programs that will directly communicate with teachers, principals, coaches, as well as elementary and secondary school children concerning the harmful effects of anabolic steroids.
(d) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this section, $15,000,000 for each of fiscal years 2005 through 2010.
SEC. 5. NATIONAL SURVEY ON DRUG USE AND HEALTH.
(a) IN GENERAL- The Secretary of Health and Human Services shall ensure that the National Survey on Drug Use and Health includes questions concerning the use of anabolic steroids.
(b) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this section, $1,000,000 for each of fiscal years 2005 through 2010.
--------------------------------------------------------------------------------
Anabolic Steroid Control Act of 2004
(Bye Bye 1-AD, Methyl-1-Test, and others)
October 22, 2004 - 5pm
S. 2195, the Anabolic Steroid Control Act of 2004, was signed by President Bush on Friday, October 22. It is amazing that only 14 years earlier, in 1990, anabolic steroids were banned. In 90 days, around January 22, 2005, selling andro, methyl-1-test, and other popular pro-hormones will be in the same legal status as other drugs, like cocaine and heroin. (Yes, we are living in the United States). It looks like besides the 18 new substances listed, in expands the act to include all prohormones and prosteroid supplements. (DHEA, estrogens and a few others were spared the act - for now). So buy all that you can now, before it goes away, like ephedra did.
This bill, which was introduced by Senators Joseph Biden (D-Del.) and Orrin Hatch (R-Utah), provided for the listing of steroid hormone precursors such as androstenedione ("andro") under the Controlled Substances Act. Such action effectively prohibits the marketing of these substances as dietary supplements by regulating them as Schedule III controlled substances. The U.S. Anti-Doping Agency (USADA) has called steroid precursors "the functional equivalent of steroids."
Congressman John Sweeney, another sponsor of the bill has said ?Today is a great victory for parents of athletes everywhere,? said Sweeney. ?No longer will these dangerous products be marketed to our nation?s youth, many of who are unaware of their harmful side effects. Starting today, we?ve made it a little easier for parents in their continuing struggle to keep their children safe from the dangers of illicit drugs.?
The legislation adds 18 substances to the list of banned anabolic steroids. Here is the list of banned items:
androstanediol--
3b,17b-dihydroxy-5a-androstane; and
3a,17b-dihydroxy-5a-androstane;
androstanedione (5a-androstan-3,17-dione);
androstenediol--
1-androstenediol (3b,17b-dihydroxy-5a-androst-1-ene);
1-androstenediol (3a,17b-dihydroxy-5a-androst-1-ene);
4-androstenediol (3b,17b-dihydroxy-androst-4-ene); and
5-androstenediol (3b,17b-dihydroxy-androst-5-ene);
androstenedione--
1-androstenedione ([5a]-androst-1-en-3,17-dione);
4-androstenedione (androst-4-en-3,17-dione); and
5-androstenedione (androst-5-en-3,17-dione);
bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
clostebol (4-chloro-17b-hydroxyandrost-4-en-3-one);
dehydrochloromethyltestosterone (4-chloro-17b-hydroxy-17a-methyl-androst-1,4-dien-3-one);
1-dihydrotestosterone (a.k.a. `1-testosterone') (17b-hydroxy-5a-androst-1-en-3-one);
4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-one);
ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
fluoxymesterone (9-fluoro-17a-methyl-11b,17b-dihydroxyandrost-4-en-3-one);
formebolone (2-formyl-17a-methyl-11a,17b-dihydroxyandrost-1,4-dien-3-one);
furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-furazan);
13a-ethyl-17a-hydroxygon-4-en-3-one;
4-hydroxytestosterone (4,17b-dihydroxy-androst-4-en-3-one);
4-hydroxy-19-nortestosterone (4,17b-dihydroxy-estr-4-en-3-one);
mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-one);
mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-one);
methandienone (17a-methyl-17b-hydroxyandrost-1,4-dien-3-one);
methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-ene);
methenolone (1-methyl-17b-hydroxy-5a-androst-1-en-3-one);
methyltestosterone (17a-methyl-17b-hydroxyandrost-4-en-3-one);
mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-one);
17a-methyl-*1-dihydrotestosterone (17b-hydroxy-17a-methyl-5a-androst-1-en-3-one) (a.k.a. `17-a-methyl-1-testosterone');
nandrolone (17b-hydroxyestr-4-en-3-one);
norandrostenediol--
19-nor-4-androstenediol (3b, 17b-dihydroxyestr-4-ene);
19-nor-4-androstenediol (3a, 17b-dihydroxyestr-4-ene);
19-nor-5-androstenediol (3b, 17b-dihydroxyestr-5-ene); and
19-nor-5-androstenediol (3a, 17b-dihydroxyestr-5-ene);
norandrostenedione--
19-nor-4-androstenedione (estr-4-en-3,17-dione); and
19-nor-5-androstenedione (estr-5-en-3,17-dione;
norbolethone (13b,17a-diethyl-17b-hydroxygon-4-en-3-one);
norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-one);
oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-androstan-3-one);
oxymesterone (17a-methyl-4,17b-dihydroxyandrost-4-en-3-one);
oxymetholone (17a-methyl-2-hydroxymethylene-17b-hydroxy-[5a]-androstan-3-one);
stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-eno[3,2-c]-pyrazole);
stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-en-3-one);
testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
testosterone (17b-hydroxyandrost-4-en-3-one);
tetrahydrogestrinone (13b,17a-diethyl-17b-hydroxygon-4,9,11-trien-3-one);
trenbolone (17b-hydroxyestr-4,9,11-trien-3-one); and
any salt, ester, or ether of a drug or substance described in this paragraph.'; and
--------------------------------------------------------------------------------
Here is the complete bill...
108th CONGRESS, 2d Session, S. 2195
To amend the Controlled Substances Act to clarify the definition of anabolic steroids and to provide for research and education activities relating to steroids and steroid precursors.
IN THE SENATE OF THE UNITED STATES
March 11, 2004
Mr. BIDEN (for himself, Mr. HATCH, Mr. GRASSLEY, Mr. HARKIN, Mr. STEVENS, Mr. MCCAIN, Mr. NELSON of Florida, Mrs. FEINSTEIN, Mr. ALLEN, and Ms. MURKOWSKI) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
A BILL: To amend the Controlled Substances Act to clarify the definition of anabolic steroids and to provide for research and education activities relating to steroids and steroid precursors.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the `Anabolic Steroid Control Act of 2004'.
SEC. 2. AMENDMENTS TO THE CONTROLLED SUBSTANCES ACT.
(a) DEFINITIONS- Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended--
(1) in paragraph (41)--
(A) by realigning the margin so as to align with paragraph (40); and
(B) by striking subparagraph (A) and inserting the following:
`(A) The term `anabolic steroid' means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone), and includes--
`(i) androstanediol--
`(I) 3b,17b-dihydroxy-5a-androstane; and
`(II) 3a,17b-dihydroxy-5a-androstane;
`(ii) androstanedione (5a-androstan-3,17-dione);
`(iii) androstenediol--
`(I) 1-androstenediol (3b,17b-dihydroxy-5a-androst-1-ene);
`(II) 1-androstenediol (3a,17b-dihydroxy-5a-androst-1-ene);
`(III) 4-androstenediol (3b,17b-dihydroxy-androst-4-ene); and
`(IV) 5-androstenediol (3b,17b-dihydroxy-androst-5-ene);
`(iv) androstenedione--
`(I) 1-androstenedione ([5a]-androst-1-en-3,17-dione);
`(II) 4-androstenedione (androst-4-en-3,17-dione); and
`(III) 5-androstenedione (androst-5-en-3,17-dione);
`(v) bolasterone (7a,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
`(vi) boldenone (17b-hydroxyandrost-1,4,-diene-3-one);
`(vii) calusterone (7b,17a-dimethyl-17b-hydroxyandrost-4-en-3-one);
`(viii) clostebol (4-chloro-17b-hydroxyandrost-4-en-3-one);
`(ix) dehydrochloromethyltestosterone (4-chloro-17b-hydroxy-17a-methyl-androst-1,4-dien-3-one);
`(x) *1-dihydrotestosterone (a.k.a. `1-testosterone') (17b-hydroxy-5a-androst-1-en-3-one);
`(xi) 4-dihydrotestosterone (17b-hydroxy-androstan-3-one);
`(xii) drostanolone (17b-hydroxy-2a-methyl-5a-androstan-3-one);
`(xiii) ethylestrenol (17a-ethyl-17b-hydroxyestr-4-ene);
`(xiv) fluoxymesterone (9-fluoro-17a-methyl-11b,17b-dihydroxyandrost-4-en-3-one);
`(xv) formebolone (2-formyl-17a-methyl-11a,17b-dihydroxyandrost-1,4-dien-3-one);
`(xvi) furazabol (17a-methyl-17b-hydroxyandrostano[2,3-c]-furazan);
`(xvii) 13a-ethyl-17a-hydroxygon-4-en-3-one;
`(xviii) 4-hydroxytestosterone (4,17b-dihydroxy-androst-4-en-3-one);
`(xix) 4-hydroxy-19-nortestosterone (4,17b-dihydroxy-estr-4-en-3-one);
`(xx) mestanolone (17a-methyl-17b-hydroxy-5a-androstan-3-one);
`(xxi) mesterolone (1a-methyl-17b-hydroxy-[5a]-androstan-3-one);
`(xxii) methandienone (17a-methyl-17b-hydroxyandrost-1,4-dien-3-one);
`(xxiii) methandriol (17a-methyl-3b,17b-dihydroxyandrost-5-ene);
`(xxiv) methenolone (1-methyl-17b-hydroxy-5a-androst-1-en-3-one);
`(xxv) methyltestosterone (17a-methyl-17b-hydroxyandrost-4-en-3-one);
`(xxvi) mibolerone (7a,17a-dimethyl-17b-hydroxyestr-4-en-3-one);
`(xxvii) 17a-methyl-*1-dihydrotestosterone (17b-hydroxy-17a-methyl-5a-androst-1-en-3-one) (a.k.a. `17-a-methyl-1-testosterone');
`(xxviii) nandrolone (17b-hydroxyestr-4-en-3-one);
`(xxix) norandrostenediol--
`(I) 19-nor-4-androstenediol (3b, 17b-dihydroxyestr-4-ene);
`(II) 19-nor-4-androstenediol (3a, 17b-dihydroxyestr-4-ene);
`(III) 19-nor-5-androstenediol (3b, 17b-dihydroxyestr-5-ene); and
`(IV) 19-nor-5-androstenediol (3a, 17b-dihydroxyestr-5-ene);
`(xxx) norandrostenedione--
`(I) 19-nor-4-androstenedione (estr-4-en-3,17-dione); and
`(II) 19-nor-5-androstenedione (estr-5-en-3,17-dione;
`(xxxi) norbolethone (13b,17a-diethyl-17b-hydroxygon-4-en-3-one);
`(xxxii) norclostebol (4-chloro-17b-hydroxyestr-4-en-3-one);
`(xxxiii) norethandrolone (17a-ethyl-17b-hydroxyestr-4-en-3-one);
`(xxxiv) oxandrolone (17a-methyl-17b-hydroxy-2-oxa-[5a]-androstan-3-one);
`(xxxv) oxymesterone (17a-methyl-4,17b-dihydroxyandrost-4-en-3-one);
`(xxxvi) oxymetholone (17a-methyl-2-hydroxymethylene-17b-hydroxy-[5a]-androstan-3-one);
`(xxxvii) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-eno[3,2-c]-pyrazole);
`(xxxviii) stenbolone (17b-hydroxy-2-methyl-[5a]-androst-1-en-3-one);
`(xxxix) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);
`(xl) testosterone (17b-hydroxyandrost-4-en-3-one);
`(xli) tetrahydrogestrinone (13b,17a-diethyl-17b-hydroxygon-4,9,11-trien-3-one);
`(xlii) trenbolone (17b-hydroxyestr-4,9,11-trien-3-one); and
`(xliii) any salt, ester, or ether of a drug or substance described in this paragraph.'; and
(2) in paragraph (44), by inserting `anabolic steroids,' after `marihuana,'.
(b) AUTHORITY AND CRITERIA FOR CLASSIFICATION- Section 201(g) of the Controlled Substances Act (21 U.S.C. 811(g)) is amended--
(1) in paragraph (1), by striking `substance from a schedule if such substance' and inserting `drug which contains a controlled substance from the application of titles II and III of the Comprehensive Drug Abuse Prevention and Control Act (21 U.S.C. 802 et seq.) if such drug'; and
(2) in paragraph (3), by adding at the end the following:
`(C) Upon the recommendation of the Secretary of Health and Human Services, a compound, mixture, or preparation which contains any anabolic steroid, which is intended for administration to a human being or an animal, and which, because of its concentration, preparation, formulation or delivery system, does not present any significant potential for abuse.'.
(c) ANABOLIC STEROIDS CONTROL ACT- Section 1903 of the Anabolic Steroids Control Act of 1990 (Public Law 101-647) is amended--
(1) by striking subsection (a); and
(2) by redesignating subsections (b) and (c) as subsections (a) and (b), respectively.
SEC. 3. SENTENCING COMMISSION GUIDELINES.
The United States Sentencing Commission shall--
(1) review the Federal sentencing guidelines with respect to offenses involving anabolic steroids;
(2) consider amending the Federal sentencing guidelines to provide for increased penalties with respect to offenses involving anabolic steroids in a manner that reflects the seriousness of such offenses and the need to deter anabolic steroid trafficking and use; and
(3) take such other action that the Commission considers necessary to carry out this section.
SEC. 4. PREVENTION AND EDUCATION PROGRAMS.
(a) IN GENERAL- The Secretary of Health and Human Services (referred to in this Act as the `Secretary') shall award grants to public and nonprofit private entities to enable such entities to carry out science-based education programs in elementary and secondary schools to highlight the harmful effects of anabolic steroids.
(b) ELIGIBILITY-
(1) APPLICATION- To be eligible for grants under subsection (a), an entity shall prepare and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require.
(2) PREFERENCE- In awarding grants under subsection (a), the Secretary shall give preference to applicants that intend to use grant funds to carry out programs based on--
(A) the Athletes Training and Learning to Avoid Steroids program;
(B) the Athletes Targeting Healthy Exercise and Nutrition Alternatives program; and
(C) other programs determined to be effective by the National Institute on Drug Abuse.
(c) USE OF FUNDS- Amounts received under a grant under subsection (a) shall be used primarily for education programs that will directly communicate with teachers, principals, coaches, as well as elementary and secondary school children concerning the harmful effects of anabolic steroids.
(d) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this section, $15,000,000 for each of fiscal years 2005 through 2010.
SEC. 5. NATIONAL SURVEY ON DRUG USE AND HEALTH.
(a) IN GENERAL- The Secretary of Health and Human Services shall ensure that the National Survey on Drug Use and Health includes questions concerning the use of anabolic steroids.
(b) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated to carry out this section, $1,000,000 for each of fiscal years 2005 through 2010.
